Pharmacist Medication Insights: Vibegron for Overactive Bladder

Video

Gemtesa (vibegron; Urovant Sciences) tablets are approved to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Gemtesa (vibegron; Urovant Sciences) tablets are indicated to treat overactive bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency.

OAB results from the involuntary contraction of the detrusor. Symptoms can include a sudden urge to urinate that is difficult to control, unintentional loss of urine immediately after an urgent need to urinate, urinating 8 or more times in 24 hours, and waking more than twice nightly to urinate.

OAB affects more than 30 million adults in the United States and often significantly affects daily activities.

Related Videos
BillionPhotos.com - stock.adobe.com
Whole psilocybin mushroom in a clear medication capsule | Image credit: Zim - stock.adobe.com
Patient suffering from atopic dermatitis -- Image credit: Nikkikii | stock.adobe.com
Image credit: Fabio Balbi | stock.adobe.com
Image credit: Melita - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.